SCHEMBL8237161

SCHEMBL8237161

Cn1c(-c2cccnc2)nnc1[S+](C)[O-]

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.44
ALDH1A1 P00352 5/20 0.44
CYP2A6 P11509 2/20 0.44
CYP2A13 Q16696 1/20 0.44
GAA P10253 1/20 0.43
LMNA P02545 3/20 0.43
RAB9A P51151 2/20 0.43
POLB P06746 1/20 0.43
HIF1A Q16665 2/20 0.43
MAPT P10636 2/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
CYP11B2 P19099 2/20 0.41
CYP1A2 P05177 2/20 0.41
CYP3A4 P08684 2/20 0.41
HSD17B10 Q99714 2/20 0.41
HK1 P19367 1/20 0.41
HKDC1 Q2TB90 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9217722 0.82 HSD11B1 (0.49) TSHRALDH1A1KMT2AL3MBTL1
SCHEMBL9525466 0.81 SMN1; SMN2 (0.42) TSHRALDH1A1GAALMNAPOLB
SCHEMBL12704750 0.77 ALDH1A1 (0.50) TSHRALDH1A1CYP2A6CYP2A13GAA
SCHEMBL2819453 0.76 CYP2A6 (0.51) ALDH1A1CYP2A6CYP2A13GAAHIF1A
SCHEMBL1544974 0.74 ALDH1A1 (0.50) TSHRALDH1A1CYP2A6CYP2A13GAA
Hydrochloric Acid SCHEMBL4705447 0.73 ALDH1A1 (0.49) TSHRALDH1A1CYP2A6CYP2A13GAA
SCHEMBL1545223 0.72 TSHR (0.59) TSHRALDH1A1GAALMNARAB9A
SCHEMBL1545248 0.72 HK1 (0.46) TSHRALDH1A1CYP2A6CYP2A13GAA
SCHEMBL9226695 0.72 HSD11B1 (0.51) TSHRALDH1A1MAPTCYP1A2CYP3A4
SCHEMBL2893222 0.71 TSHR (0.48) TSHRALDH1A1CYP2A6GAALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007040982-A1 5- (PHENYLISOXAZOLYLETHOXY) -TRIAZOL- 3 -YL SUBSTITUTED PYRIDINE COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL, PSYCHIATRIC OR PAIN DISORDERS ASTRAZENECA AB (SE) 2007-04-12 WO disclosed